Contribution of research networks to a clinical trial of antidepressants in people with dementia

Abstract

Background.The Mental Health Research Network and Dementia and Neurodegenerative Diseases Research Network were established in the UK to increase research capacity and activity; the former in mental health generally, and the latter specifically in neurodegenerative disorders including dementia. Little evidence exists on the impact of these networks on research in mental health of older people.AimsTo examine research network support to a multi-centre randomised controlled trial of antidepressants in people with depression superimposed on dementia.MethodQualitative questionnaires were completed by principal investigators, trial-funded research workers and clinical study officers (CSOs) of the research networks.ResultsResearch network contribution was much valued by principal investigators and the nine research teams. CSOs boosted the recruitment campaign in a challenging environment and enhanced assessment processes. Some problems with consistency and staff turnover were raised.ConclusionResearch network input can make an appreciable difference to the process and outcome of a multi-centre clinical trial.